Finance

Lists
SER:NYSEAMERICAN
Serina Therapeutics Inc
$2.66
+1.34%
(+0.035) 1D
Sep 3, 12:47:36 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SER...
Open
$2.68
High
$2.68
Low
$2.58
Mkt. cap
67.44M
Avg. vol.
51.06K
Volume
14.20K
52-wk high
$5.83
52-wk low
$1.22
EPS
-$1.88
Beta
1.20
Shares outstanding
25.40M
No. of employees
16
Open
$2.68
High
$2.68
Low
$2.58
Mkt. cap
67.44M
Avg. vol.
51.06K
Volume
14.20K
52-wk high
$5.83
52-wk low
$1.22
EPS
-$1.88
Beta
1.20
Shares outstanding
25.40M
No. of employees
16
About Serina Therapeutics Inc
CEO-
Employees16
Founded2006
HeadquartersHuntsville, Alabama, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
3.65M
3.40M
3.20M
3.82M
Cost of revenue
3.65M
3.40M
3.20M
3.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.74M
2.81M
3.08M
2.97M
Operating expense
2.74M
2.81M
3.08M
2.97M
Total operating expenses
6.39M
6.21M
6.28M
6.78M
Operating income
-6.39M
-6.21M
-6.28M
-6.78M
Other non operating income
1.80M
3.09M
1.19M
631.00K
EBT including unusual items
-4.60M
-3.32M
-6.89M
-6.36M
EBT excluding unusual items
-4.60M
-3.32M
-5.28M
-6.36M
Income tax expense
-
18.00K
7.00K
-
Effective tax rate
-
-0.54%
-0.10%
-
Other operating expenses
-
-
-
-
Net income
-4.58M
-3.34M
-6.90M
-6.36M
Net profit margin
-
-
-
-
Earnings per share
-0.51
-0.31
-0.53
-0.52
Interest and investment income
-
-
-
-
Interest expense
-6.00K
-198.00K
-189.00K
-203.00K
Net interest expenses
-6.00K
-198.00K
-189.00K
-203.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.38M
-6.18M
-6.26M
-6.77M
Gain or loss from assets sale
-
257.00K
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps